CME
CME Group Inc. NASDAQ Listed Dec 6, 2002$286.86
Mkt Cap $103.9B
52w Low $257.17
41.2% of range
52w High $329.16
50d MA $301.26
200d MA $281.88
P/E (TTM)
25.9x
EV/EBITDA
17.1x
P/B
3.6x
Debt/Equity
0.1x
ROE
15.3%
P/FCF
23.4x
RSI (14)
—
ATR (14)
—
Beta
0.30
50d MA
$301.26
200d MA
$281.88
Avg Volume
2.4M
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
20 South Wacker Drive · Chicago, IL 60606 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | AMC | 3.34 | 3.36 | +0.6% | 285.71 | -0.2% | -0.1% | -0.2% | -1.3% | -0.4% | +0.5% | — |
| Feb 4, 2026 | AMC | 2.75 | 2.77 | +0.7% | 294.62 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% | — |
| Oct 22, 2025 | AMC | 2.63 | 2.68 | +1.9% | 267.81 | +1.9% | +0.4% | +0.6% | +1.2% | -0.6% | -2.3% | — |
| Jul 23, 2025 | AMC | 2.91 | 2.96 | +1.7% | 276.48 | -0.0% | +0.3% | +1.1% | -0.9% | -0.7% | +0.5% | — |
| Apr 23, 2025 | AMC | 2.80 | 2.80 | +0.0% | 261.48 | +0.0% | +0.7% | +1.8% | +2.5% | +4.2% | +6.0% | — |
| Feb 12, 2025 | AMC | 2.46 | 2.52 | +2.4% | 248.96 | +0.6% | +0.5% | -1.4% | -0.4% | +0.7% | -0.3% | — |
| Oct 23, 2024 | AMC | 2.66 | 2.68 | +0.8% | 227.14 | -0.2% | +1.1% | -0.4% | +0.4% | -0.0% | +0.1% | — |
| Jul 24, 2024 | AMC | 2.53 | 2.56 | +1.2% | 197.25 | +0.1% | +1.1% | +1.7% | +0.8% | -0.0% | -1.8% | — |
| Apr 24, 2024 | AMC | 2.45 | 2.50 | +2.0% | 212.59 | -0.1% | -0.0% | -0.8% | -1.4% | -1.4% | -2.1% | — |
| Feb 14, 2024 | AMC | 2.28 | 2.37 | +3.9% | 215.18 | -0.4% | -1.9% | -1.4% | -1.9% | -0.1% | +1.3% | — |
| Oct 25, 2023 | AMC | 2.22 | 2.25 | +1.4% | 214.08 | +0.6% | +0.6% | -2.4% | -1.3% | -0.3% | -1.5% | — |
| Jul 26, 2023 | AMC | 2.20 | 2.30 | +4.5% | 198.75 | +0.5% | -0.0% | +0.3% | +0.1% | +0.5% | +0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 | Morgan Stanley | Maintains | Overweight → Overweight | — | $285.71 | $285.11 | -0.2% | -0.1% | -0.2% | -1.3% | -0.4% | +0.5% |
| Apr 23 | Barclays | Maintains | Equal Weight → Equal Weight | — | $285.71 | $285.11 | -0.2% | -0.1% | -0.2% | -1.3% | -0.4% | +0.5% |
| Apr 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $297.03 | $296.89 | -0.0% | -0.0% | -0.3% | -3.2% | -3.2% | -4.3% |
| Apr 13 | Barclays | Maintains | Equal Weight → Equal Weight | — | $295.30 | $297.12 | +0.6% | +1.8% | +0.6% | +0.5% | +0.3% | -2.6% |
| Apr 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $298.93 | $300.86 | +0.6% | -1.2% | +0.6% | -0.6% | -0.7% | -0.9% |
| Apr 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $310.58 | $299.36 | -3.6% | -2.5% | -3.8% | -4.9% | -3.2% | -4.4% |
| Mar 4 | Argus | Downgrade | Buy → Hold | — | $325.13 | $319.82 | -1.6% | -1.6% | -2.6% | -2.5% | -1.9% | -5.8% |
| Feb 5 | JP Morgan | Maintains | Underweight → Underweight | — | $294.62 | $297.00 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% |
| Feb 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $294.62 | $297.00 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% |
| Feb 5 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $294.62 | $297.00 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% |
| Feb 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $294.62 | $297.00 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% |
| Feb 5 | TD Cowen | Maintains | Buy → Buy | — | $294.62 | $297.00 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% |
| Jan 15 | Morgan Stanley | Maintains | Overweight → Overweight | — | $275.23 | $274.39 | -0.3% | -1.0% | +1.6% | +1.7% | +1.4% | +2.2% |
| Jan 14 | TD Cowen | Upgrade | Hold → Buy | — | $268.45 | $270.26 | +0.7% | +2.5% | +1.5% | +4.1% | +4.3% | +4.0% |
| Dec 22 | Morgan Stanley | Maintains | Overweight → Overweight | — | $269.09 | $268.50 | -0.2% | +1.5% | +2.4% | +2.7% | +2.8% | +3.5% |
| Dec 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $272.40 | $272.00 | -0.1% | +0.4% | -0.1% | +0.2% | +0.5% | -2.3% |
| Nov 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $279.58 | $281.55 | +0.7% | +1.4% | +2.0% | -0.2% | -0.1% | -2.5% |
| Oct 23 | Deutsche Bank | Upgrade | Hold → Buy | — | $267.81 | $272.79 | +1.9% | +0.4% | +0.6% | +1.2% | -0.6% | -2.3% |
| Oct 23 | UBS | Maintains | Neutral → Neutral | — | $267.81 | $272.79 | +1.9% | +0.4% | +0.6% | +1.2% | -0.6% | -2.3% |
| Oct 23 | Morgan Stanley | Maintains | Overweight → Overweight | — | $267.81 | $272.79 | +1.9% | +0.4% | +0.6% | +1.2% | -0.6% | -2.3% |
| Oct 13 | Raymond James | Maintains | Outperform → Outperform | — | $271.45 | $268.29 | -1.2% | -0.1% | -1.6% | -1.2% | -3.3% | -1.3% |
| Oct 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $263.60 | $263.58 | -0.0% | +0.5% | +2.0% | +3.0% | +2.9% | +1.4% |
| Oct 1 | Morgan Stanley | Maintains | Overweight → Overweight | — | $270.19 | $270.19 | +0.0% | -1.6% | -1.8% | -2.0% | -3.0% | -2.4% |
| Sep 25 | JP Morgan | Maintains | Underweight → Underweight | — | $264.43 | $265.61 | +0.4% | +1.6% | +2.2% | +3.0% | +2.2% | +0.5% |
| Sep 25 | Citigroup | Upgrade | Neutral → Buy | — | $264.43 | $265.61 | +0.4% | +1.6% | +2.2% | +3.0% | +2.2% | +0.5% |
| Sep 8 | UBS | Maintains | Neutral → Neutral | — | $261.94 | $261.61 | -0.1% | +0.2% | -0.2% | -0.8% | +0.2% | +0.1% |
| Jul 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $276.48 | $276.46 | -0.0% | +0.3% | +1.1% | -0.9% | -0.7% | +0.5% |
| Jul 24 | UBS | Downgrade | Buy → Neutral | — | $276.48 | $276.46 | -0.0% | +0.3% | +1.1% | -0.9% | -0.7% | +0.5% |
| Jul 24 | Oppenheimer | Maintains | Outperform → Outperform | — | $276.48 | $276.46 | -0.0% | +0.3% | +1.1% | -0.9% | -0.7% | +0.5% |
| Jul 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $277.06 | $274.10 | -1.1% | -0.7% | +0.2% | +0.3% | -0.9% | -0.7% |
| Jul 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $275.64 | $275.64 | +0.0% | -0.2% | -0.2% | +0.5% | -0.2% | +0.7% |
| Jul 3 | Citigroup | Maintains | Neutral → Neutral | — | $275.82 | $275.83 | +0.0% | +0.3% | +2.4% | -0.1% | -0.1% | -0.2% |
| Jun 4 | Oppenheimer | Maintains | Outperform → Outperform | — | $282.31 | $282.19 | -0.0% | -1.6% | -2.6% | -2.9% | -4.9% | -5.7% |
| Apr 25 | UBS | Maintains | Buy → Buy | — | $263.27 | $263.02 | -0.1% | +1.2% | +1.8% | +3.5% | +5.2% | +5.3% |
| Apr 24 | JP Morgan | Maintains | Underweight → Underweight | — | $261.48 | $261.48 | +0.0% | +0.7% | +1.8% | +2.5% | +4.2% | +6.0% |
| Apr 24 | Oppenheimer | Maintains | Outperform → Outperform | — | $261.48 | $261.48 | +0.0% | +0.7% | +1.8% | +2.5% | +4.2% | +6.0% |
| Apr 24 | Morgan Stanley | Maintains | Overweight → Overweight | — | $261.48 | $261.48 | +0.0% | +0.7% | +1.8% | +2.5% | +4.2% | +6.0% |
| Apr 24 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $261.48 | $261.48 | +0.0% | +0.7% | +1.8% | +2.5% | +4.2% | +6.0% |
| Apr 23 | Barclays | Maintains | Equal Weight → Equal Weight | — | $265.56 | $256.65 | -3.4% | -1.5% | -0.9% | +0.3% | +0.9% | +2.6% |
| Apr 11 | Oppenheimer | Maintains | Outperform → Outperform | — | $258.39 | $259.05 | +0.3% | +1.2% | +2.1% | +1.7% | +1.2% | +1.6% |
| Apr 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $252.37 | $256.54 | +1.7% | +1.1% | +0.7% | +2.4% | +3.6% | +4.5% |
| Apr 8 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $252.37 | $256.54 | +1.7% | +1.1% | +0.7% | +2.4% | +3.6% | +4.5% |
| Apr 7 | Barclays | Maintains | Equal Weight → Equal Weight | — | $254.46 | $254.34 | -0.0% | -0.8% | +0.2% | -0.1% | +1.5% | +2.8% |
| Apr 3 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $262.54 | $264.80 | +0.9% | +2.2% | -3.1% | -3.9% | -2.9% | -3.2% |
| Apr 2 | BofA Securities | Maintains | Underperform → Underperform | — | $262.24 | $263.65 | +0.5% | +0.1% | +2.3% | -3.0% | -3.8% | -2.7% |
| Mar 10 | Raymond James | Upgrade | Market Perform → Outperform | — | $254.57 | $254.82 | +0.1% | +3.0% | +2.3% | +0.8% | +2.1% | +1.6% |
| Feb 19 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $247.85 | $248.12 | +0.1% | +1.2% | +0.2% | +0.4% | -0.0% | +1.2% |
| Feb 14 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $250.11 | $248.73 | -0.6% | -1.9% | -0.9% | +0.3% | -0.7% | -0.5% |
| Feb 13 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $248.96 | $250.44 | +0.6% | +0.5% | -1.4% | -0.4% | +0.7% | -0.3% |
| Feb 13 | JP Morgan | Maintains | Underweight → Underweight | — | $248.96 | $250.44 | +0.6% | +0.5% | -1.4% | -0.4% | +0.7% | -0.3% |
No insider trades available.
8-K
CME Group Inc. -- 8-K Filing
CME Group must maintain compliance with a consolidated tangible net worth test under its existing 364-day credit facility, a standard covenant protecting lenders against financial deterioration.
Apr 27
8-K
CME Group Inc. -- 8-K Filing
CME Group disclosed non-GAAP financial measures in its earnings report, providing reconciliations to GAAP equivalents for investor comparison and transparency.
Apr 22
8-K
CME Group Inc. -- 8-K Filing
CME Group disclosed non-GAAP financial measures in its 8-K filing with reconciliations to GAAP equivalents, allowing investors to evaluate performance using both adjusted and standard accounting metrics.
Feb 4
8-K · 7.01
! Medium
CME Group Inc. -- 8-K 7.01: Regulation FD Disclosure
CME Group notified clients of pricing changes through a special executive report, indicating potential adjustments to its fee structure that could affect trading costs for market participants.
Feb 2
Data updated apr 25, 2026 1:57am
· Source: massive.com